Latest Breaking News On - Primary open angle glaucoma - Page 1 : comparemela.com

Ciliatech s glaucoma implant CID receives favorable opinion on treating both open and narrow angle forms of disease

First independent observations, presented by Dr. Leon Au, leading consultant ophthalmology and eye surgeon, during ICGS 2024 in Abu Dhabi, underscore CID’s strong potential as treatment option for glaucoma Substantial IOP lowering effect from stand-alone procedureSurgical placement of suprachoroidal device without p.

United kingdomPhilippe sourdilleSahil syedOlivier benoitAbu dhabiLilit voskanyanMalayan centerInternational congressCilioscleral interposition deviceManchester royal eye hospitalNew deviceGlaucoma surgeryMonth outcomesNarrow angle glaucomaIntraocular pressurePrimary open angle glaucoma

Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today.

United statesDeborah ristvedtMichael raizmanValerie trubnikChristy bensonFritz hengererManjool shahEdward yungBlake williamsonI paul singhAli salimiJohn berdahlLike ahmedCristos ifantidesMitchell schultzBrandon ayres

Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update

Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Investorsocular therapeutixdonald notmanchiefMediaicr westwickeben shannonAntony mattessichCenters for medicareInc condensed consolidated statements of operationsDrug administrationExchange commissionOcular therapeutix incMedicaid servicesOverall designFirst pivotal trialSpecial protocol assessmentExpect first subject dosedPrimary open angle glaucomaOcular hypertension anticipatedEarly april

Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

FORT WORTH, Texas, October 30, 2023 Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

Yerba buenaUnited statesSan franciscoFort worthNina berrocalHydrus microstentAllen trangIsra husseinChristina wengDonaldj damicoEric jenningsActa ophthalmol scandAlcon fidelisStevenm podosJohn kanellopoulousMark humayun

Thea Pharma Inc Launches IYUZEH™ (latanoprost ophthalmic solution) 0 005% in the U S

/PRNewswire/ Thea Pharma Inc. ("Thea"), the U.S. subsidiary of Europe s leading independent ophthalmic-focused pharmaceutical company, Théa, dedicated to.

United statesClin ophthalmolSusan bentonHenri chibretThea pharmaJason bacharachPrevention national centerA patient assistance programCenters for diseasePrnewswire thea pharma incThea pharma incHealth technolAmerican glaucoma societyOffice visits for glaucomaHealth statisticsDrug administration